Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > New Evidence on Infection as Chronic Disease Trigger Published, Debated by World-Class Scientists

Abstract:
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") announces new evidence that may help solve one of the great puzzles of 21st century medicine was published today in a special section of the Journal of Investigative Medicine. It features leading scientists in the field brought together by The American Federation for Medical Research and the American Physiological Society.

New Evidence on Infection as Chronic Disease Trigger Published, Debated by World-Class Scientists

TAMPA, FL | Posted on January 31st, 2007

Is chronic disease triggered by an infection? New evidence comes from scientists at NASA, Mayo Clinic, and Nanobac Pharmaceuticals who pioneered investigations into infectious calcifying particles.

A condition known as calcification occurs in most diseases on the leading cause of death list and in illnesses such as kidney, gallbladder and prostate stones. Calcification is also linked to chronic inflammation in atherosclerosis and end-stage renal disease, but it is unclear how this occurs.

Half-a-dozen papers in the Journal resulted from a symposium that assembled, for the first time in medical history, experts from biology, medicine and geology to debate these possible causes of calcification: chemical crystallization; cell-mediated crystallization; and potentially infectious calcifying nanoparticles (CNPs) that generate calcification.

One conclusion by symposium organizers: Although infection is just one of three potential causes of calcification, it deserves focus as a chronic disease trigger, based on new evidence presented. "Increasingly, micro-organisms are being identified as an unexpected cause of disease..." writes symposium co-organizer and Mayo Clinic scientist Dr. Virginia Miller.

The symposium considered works by Dr. Neva Ciftcioglu and Dr. Olavi Kajander, lead scientists with Nanobac Pharmaceuticals, as well as two other works by Mayo researchers, which provide evidence that calcifying nanoparticles might be infectious and spark calcification in disease.

Although Dr. Miller says the idea of infectious nanoparticles is still controversial, she concludes that, "Nanoparticles might serve as an inflammatory stimulus that initiates cell transdifferentiation, stimulate the formation of matrix vesicles, or simply form a nidus for subsequent inorganic calcium accumulation."

Participants in the symposium included scientists from such world-class institutions as UCLA and various institutes in Europe.

Scientists from Nanobac Pharmaceuticals are the leading investigators on the issue of infection as a possible cause of calcification, and have published the most papers on this topic.

####

About Nanobac Pharmaceuticals Inc.
Nanobac Pharmaceuticals Inc. is headquartered in Tampa, Florida. For more information, visit our website at: http://www.nanobac.com .

Investors are cautioned that certain statements in this document, some statements in periodic press releases and some oral statements of Nanobac Pharmaceuticals, Inc. officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-Looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future Nanobac Pharmaceuticals, Inc. actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-Looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and Nanobac Pharmaceuticals, Inc. has no specific intention to update these statements.

For more information, please click here

Contacts:
Nanobac Pharmaceuticals, Tampa
Benedict Maniscalco, 813-264-2241

Redwood Consultants
Jens Dalsgaard, 415-884-0348

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Scientists develop promising vaccine method against recurrent UTI November 19th, 2021

Cancer cells use ‘tiny tentacles’ to suppress the immune system: With the power of nanotechnology, investigators have discovered that cancer cells strengthen by forming nanotubes that they use to suck mitochondria out of immune cells November 19th, 2021

Quantum brain sensors could be crucial in spotting dementia after University of Sussex scientists find they can track brain waves: Sensors introduce important new method to spot bio-marker for brain diseases • Accurate timings of when brain signals fire demonstrated for first tim November 19th, 2021

'Dancing molecules' successfully repair severe spinal cord injuries: After single injection, paralyzed animals regained ability to walk within four weeks November 12th, 2021

Discoveries

Developing high-performance MXene electrodes for next-generation powerful battery November 19th, 2021

Efficient photon upconversion at an organic semiconductor interface November 19th, 2021

Quantum brain sensors could be crucial in spotting dementia after University of Sussex scientists find they can track brain waves: Sensors introduce important new method to spot bio-marker for brain diseases • Accurate timings of when brain signals fire demonstrated for first tim November 19th, 2021

New microscopy method offers 3D tracking of 100 single molecules at once November 19th, 2021

Announcements

Efficient photon upconversion at an organic semiconductor interface November 19th, 2021

Quantum brain sensors could be crucial in spotting dementia after University of Sussex scientists find they can track brain waves: Sensors introduce important new method to spot bio-marker for brain diseases • Accurate timings of when brain signals fire demonstrated for first tim November 19th, 2021

New microscopy method offers 3D tracking of 100 single molecules at once November 19th, 2021

Two is better than one: Single-atom dimer electrocatalyst for green hydrogen production: Nickel-cobalt metal dimer on nitrogen-doped carbon can catalyze electrolysis under both acidic and basic conditions November 19th, 2021

Human Interest/Art

Graphene nanotubes revolutionize touch screen use for prosthetic hands August 3rd, 2021

JEOL Announces 2020 Microscopy Image Grand Prize Winners January 7th, 2021

No ink needed for these graphene artworks: Artist employs Rice University lab's laser-induced graphene as medium for ultramodern art May 3rd, 2019

'Quantum Rhapsodies' performance explores quantum physics, its role in our universe April 5th, 2019

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project